These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 38160882

  • 1. Long-term Follow-up of a Phase 1/2a Clinical Trial of a Stem Cell-Derived Bioengineered Retinal Pigment Epithelium Implant for Geographic Atrophy.
    Humayun MS, Clegg DO, Dayan MS, Kashani AH, Rahhal FM, Avery RL, Salehi-Had H, Chen S, Chan C, Palejwala N, Ingram A, Mitra D, Pennington BO, Hinman C, Faynus MA, Bailey JK, Johnson LV, Lebkowski JS.
    Ophthalmology; 2024 Jun; 131(6):682-691. PubMed ID: 38160882
    [Abstract] [Full Text] [Related]

  • 2. Surgical Method for Implantation of a Biosynthetic Retinal Pigment Epithelium Monolayer for Geographic Atrophy: Experience from a Phase 1/2a Study.
    Kashani AH, Uang J, Mert M, Rahhal F, Chan C, Avery RL, Dugel P, Chen S, Lebkowski J, Clegg DO, Hinton DR, Humayun MS.
    Ophthalmol Retina; 2020 Mar; 4(3):264-273. PubMed ID: 31786135
    [Abstract] [Full Text] [Related]

  • 3. One-Year Follow-Up in a Phase 1/2a Clinical Trial of an Allogeneic RPE Cell Bioengineered Implant for Advanced Dry Age-Related Macular Degeneration.
    Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Chen S, Chan C, Palejwala N, Ingram A, Dang W, Lin CM, Mitra D, Pennington BO, Hinman C, Faynus MA, Bailey JK, Mohan S, Rao N, Johnson LV, Clegg DO, Hinton DR, Humayun MS.
    Transl Vis Sci Technol; 2021 Aug 12; 10(10):13. PubMed ID: 34613357
    [Abstract] [Full Text] [Related]

  • 4. Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration: Phase 2b Study.
    Heier JS, Ho AC, Samuel MA, Chang T, Riemann CD, Kitchens JW, Slakter JS, Leiderman YI, Spencer R, Williams GA, Hickson-Curran SB, Keane M, Baldassarre JS, Prelude Study Group.
    Ophthalmol Retina; 2020 Apr 12; 4(4):384-393. PubMed ID: 32033908
    [Abstract] [Full Text] [Related]

  • 5. A bioengineered retinal pigment epithelial monolayer for advanced, dry age-related macular degeneration.
    Kashani AH, Lebkowski JS, Rahhal FM, Avery RL, Salehi-Had H, Dang W, Lin CM, Mitra D, Zhu D, Thomas BB, Hikita ST, Pennington BO, Johnson LV, Clegg DO, Hinton DR, Humayun MS.
    Sci Transl Med; 2018 Apr 04; 10(435):. PubMed ID: 29618560
    [Abstract] [Full Text] [Related]

  • 6. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial.
    Brader HS, Ying GS, Martin ER, Maguire MG, Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) Research Group.
    Ophthalmology; 2013 Sep 04; 120(9):1871-9. PubMed ID: 23622873
    [Abstract] [Full Text] [Related]

  • 7. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S, Toth CA, Daniel E, Grunwald JE, Maguire MG, Ying GS, Huang J, Martin DF, Jaffe GJ, Comparison of Age-related Macular Degeneration Treatments Trials Research Group.
    Ophthalmology; 2016 Apr 04; 123(4):865-75. PubMed ID: 26783095
    [Abstract] [Full Text] [Related]

  • 8. Transplantation of Human Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells in Macular Degeneration.
    Mehat MS, Sundaram V, Ripamonti C, Robson AG, Smith AJ, Borooah S, Robinson M, Rosenthal AN, Innes W, Weleber RG, Lee RWJ, Crossland M, Rubin GS, Dhillon B, Steel DHW, Anglade E, Lanza RP, Ali RR, Michaelides M, Bainbridge JWB.
    Ophthalmology; 2018 Nov 04; 125(11):1765-1775. PubMed ID: 29884405
    [Abstract] [Full Text] [Related]

  • 9. Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies.
    Schwartz SD, Regillo CD, Lam BL, Eliott D, Rosenfeld PJ, Gregori NZ, Hubschman JP, Davis JL, Heilwell G, Spirn M, Maguire J, Gay R, Bateman J, Ostrick RM, Morris D, Vincent M, Anglade E, Del Priore LV, Lanza R.
    Lancet; 2015 Feb 07; 385(9967):509-16. PubMed ID: 25458728
    [Abstract] [Full Text] [Related]

  • 10. Subretinal implantation of a monolayer of human embryonic stem cell-derived retinal pigment epithelium: a feasibility and safety study in Yucatán minipigs.
    Koss MJ, Falabella P, Stefanini FR, Pfister M, Thomas BB, Kashani AH, Brant R, Zhu D, Clegg DO, Hinton DR, Humayun MS.
    Graefes Arch Clin Exp Ophthalmol; 2016 Aug 07; 254(8):1553-1565. PubMed ID: 27335025
    [Abstract] [Full Text] [Related]

  • 11. A phase I clinical trial of human embryonic stem cell-derived retinal pigment epithelial cells for early-stage Stargardt macular degeneration: 5-years' follow-up.
    Li SY, Liu Y, Wang L, Wang F, Zhao TT, Li QY, Xu HW, Meng XH, Hao J, Zhou Q, Wang L, Yin ZQ.
    Cell Prolif; 2021 Sep 07; 54(9):e13100. PubMed ID: 34347352
    [Abstract] [Full Text] [Related]

  • 12. Survival of an HLA-mismatched, bioengineered RPE implant in dry age-related macular degeneration.
    Kashani AH, Lebkowski JS, Hinton DR, Zhu D, Faynus MA, Chen S, Rahhal FM, Avery RL, Salehi-Had H, Chan C, Palejwala N, Ingram A, Dang W, Lin CM, Mitra D, Martinez-Camarillo JC, Bailey J, Arnold C, Pennington BO, Rao N, Johnson LV, Clegg DO, Humayun MS.
    Stem Cell Reports; 2022 Mar 08; 17(3):448-458. PubMed ID: 35120620
    [Abstract] [Full Text] [Related]

  • 13. Phase 1 clinical study of an embryonic stem cell-derived retinal pigment epithelium patch in age-related macular degeneration.
    da Cruz L, Fynes K, Georgiadis O, Kerby J, Luo YH, Ahmado A, Vernon A, Daniels JT, Nommiste B, Hasan SM, Gooljar SB, Carr AF, Vugler A, Ramsden CM, Bictash M, Fenster M, Steer J, Harbinson T, Wilbrey A, Tufail A, Feng G, Whitlock M, Robson AG, Holder GE, Sagoo MS, Loudon PT, Whiting P, Coffey PJ.
    Nat Biotechnol; 2018 Apr 08; 36(4):328-337. PubMed ID: 29553577
    [Abstract] [Full Text] [Related]

  • 14. Subretinal Transplantation of Human Embryonic Stem Cell Derived-retinal Pigment Epithelial Cells into a Large-eyed Model of Geographic Atrophy.
    Petrus-Reurer S, Bartuma H, Aronsson M, Westman S, Lanner F, Kvanta A.
    J Vis Exp; 2018 Jan 22; (131):. PubMed ID: 29443034
    [Abstract] [Full Text] [Related]

  • 15. Effect of Human Central Nervous System Stem Cell Subretinal Transplantation on Progression of Geographic Atrophy Secondary to Nonneovascular Age-Related Macular Degeneration.
    Nittala MG, Uji A, Velaga SB, Hariri AH, Naor J, Birch DG, Spencer R, Leng T, Capela A, Tsukamoto A, Ip M, Sadda SR.
    Ophthalmol Retina; 2021 Jan 22; 5(1):32-40. PubMed ID: 32562884
    [Abstract] [Full Text] [Related]

  • 16. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
    Mettu PS, Allingham MJ, Cousins SW.
    Ophthalmol Sci; 2022 Mar 22; 2(1):100086. PubMed ID: 36246181
    [Abstract] [Full Text] [Related]

  • 17. Documentation of intraretinal retinal pigment epithelium migration via high-speed ultrahigh-resolution optical coherence tomography.
    Ho J, Witkin AJ, Liu J, Chen Y, Fujimoto JG, Schuman JS, Duker JS.
    Ophthalmology; 2011 Apr 22; 118(4):687-93. PubMed ID: 21093923
    [Abstract] [Full Text] [Related]

  • 18. Optical Coherence Tomography Predictors of Risk for Progression to Non-Neovascular Atrophic Age-Related Macular Degeneration.
    Sleiman K, Veerappan M, Winter KP, McCall MN, Yiu G, Farsiu S, Chew EY, Clemons T, Toth CA, Age-Related Eye Disease Study 2 Ancillary Spectral Domain Optical Coherence Tomography Study Group.
    Ophthalmology; 2017 Dec 22; 124(12):1764-1777. PubMed ID: 28847641
    [Abstract] [Full Text] [Related]

  • 19. Combined Fundus Autofluorescence and Near Infrared Reflectance as Prognostic Biomarkers for Visual Acuity in Foveal-Sparing Geographic Atrophy.
    Lindner M, Nadal J, Mauschitz MM, Lüning A, Czauderna J, Pfau M, Schmitz-Valckenberg S, Holz FG, Schmid M, Fleckenstein M.
    Invest Ophthalmol Vis Sci; 2017 May 01; 58(6):BIO61-BIO67. PubMed ID: 28475704
    [Abstract] [Full Text] [Related]

  • 20. A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.
    Khanani AM, Maturi RK, Bagheri N, Bakall B, Boyer DS, Couvillion SS, Dhoot DS, Holekamp NM, Jamal KN, Marcus DM, Pieramici D, Aziz AA, Patki KC, Bridges WZ, Barone SB.
    Ophthalmol Sci; 2022 Jun 01; 2(2):100154. PubMed ID: 36249705
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.